Clinical Trial Update: To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating TRD205 tablets for efficacy and safety in chronic postoperative neuralgia, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Neuralgia

Drugs mentioned

• TRD205 (TRD205)

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: Chronic Postoperative Neuralgia | Phase 2 | Status: ENROLLING_BY_INVITATION